VE-cadherin and synthesis of vimentin. These effects were blocked by eNOS 54 inhibitor L-NAME. We propose that transcriptional repression of VE-cadherin 55 by nitrosative stress is involved in endothelial-mesenchymal 56 transdifferentiation in experimental PH. 57 58
Introduction 62

Pulmonary arterial hypertension (PAH) is characterized by a chronic 63
and sustained elevation in pulmonary vascular resistance, leading to right-64 ventricular pressure-overload and end-stage right heart failure (15). Driven by 65 an excess of vasoconstrictors, mitogens, pro-inflammatory, pro-thrombotic, 66
pro-fibrotic and other factors, endothelial dysfunction results in luminal 67 narrowing of small pulmonary arteries due to intimal hyperplasia, 68 vasoconstriction and thrombosis, in addition to inducing neovascularization 69 (2). The syndrome may occur as a consequence of various and seemingly 70 unrelated genetic and/or acquired conditions, which share the above 71 described manifestation (1). It is becoming increasingly recognized that the 72 aberrantly proliferating endothelial cells (EC) are of primary pathogenetic 73 significance and exhibit features of neoplastic cells, giving rise to the cancer 74 paradigm in PAH (26) . 75
A central event in epithelial tumorigenesis is the transcriptional 76 suppression of epithelial cadherin, which precipitates disruption of inter-77 cellular junctions, loss of cell polarity, resistance to apoptosis and acquisition 78 of invasiveness (13). Others and we speculate that a similar process could be 79 at play within deregulated EC in PAH and contribute to the observed 80 phenotypic shift (3). 81
The inner surface of blood vessels is lined by a single layer of EC 82 tethered by intercellular (tight-and adherens-) 
Western blotting 170
Lung tissue samples and cell pellets were homogenized in lysis buffer 171 containing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% Na-172 Dodecyl-Sulfate, 1 mM NaF, 1 mM Na 3 VO 4 , and protease inhibitor cocktail 173 (Sigma-Aldrich Co, St. Louis, MO, USA). Protein concentration was 174 determined by a colorimetric assay kit (Bio-Rad Laboratories, Inc., Hercules, 175 CA, USA). Lysates (30 μg protein per sample) were subjected to 176 electrophoresis on 10% polyacrylamide gels and transferred to polyvinylidene 177 fluoride membranes (Whatman Ltd GE Healthcare, UK). After blocking with 178 5% Bovine Serum Albumin (BSA) or 5% nonfat dry milk, membranes were 179 probed overnight at 4 0 C with one of the following primary antibodies: anti-VE-180 cadherin, anti-phospho-endothelial nitric oxide synthase (eNOS), anti-β-181 tubulin (Santa Cruz Biotechnology, Inc.), anti-vimentin, anti-inhibitory (I) κB-α, electrophoretically separated on agarose gel and visualized using PAGE 212
GelRed nucleic acid gel stain (Biotium Inc., Hayward, CA, USA). Images were 213 quantitated by using ImageJ software, and signal normalization was 214 performed in relation to the GAPDH internal control. 215
216
Cell culture and treatment 217
Rat lung microvascular EC, a generous gift from Dr RD Minshall, University of 218
Illinois at Chicago, USA, (19) were cultured in Dulbecco's Modified Eagle 219
Medium supplemented with 10% FBS and 1% penicillin-streptomycin (all 220 from Gibco, Life Technologies, USA). Cells were grown at 37°C and 5% 221 CO 2 . All experiments were performed at passage 7-9 with 70-80% 222 confluent cells, following overnight incubation in serum-free medium 223 supplemented with 0.2% BSA (AppliChem, GmbH, Germany). Cultures 224 were treated with a 10nM concentration of endothelin-1 (Sigma-Aldrich, 225
St. Louis, MO) for 5 hours. In certain experiments, cells were pre-226 incubated for 1 hour with N ω -Nitro-L-arginine methyl ester hydrochloride 227 (L-NAME, Sigma-Aldrich, St. Louis, MO), dosed at 10μΜ. 228
229
Statistical analysis 230
Statistical significance was assessed in pairwise comparisons with 231 control values by using paired Student's t test. For multiple comparisons one-232 11 way ANOVA and Newman-Keuls post-hoc test was used. All values are 233 expressed as mean ± one standard deviation and p-value less than 0.05 was 234 considered statistically significant. 235
236
Results
237
Monocrotaline injection induces pulmonary hypertension and lung cell 238 proliferation 239
Rats challenged with MCT developed PH confirmed by the presence of 240 right-ventricular hypertrophy; RV/(LV+S) was significantly elevated in rats 15 241 and 30 days after MCT injection (Fig. 1A) . On the microstructural level, we 242 observed the typical appearance of the MCT lesion (Fig. 1B) ; specifically, no 243 appreciable changes were seen at 24 hours post MCT but by day 15 there 244 was marked cellular proliferation within alveolar septa coupled with regression 245 of airspace and medial hyperplasia in small pulmonary arteries; these effects 246 were most striking by day 30. Lung cell proliferation was concurrently 247 investigated in the whole lung through PCNA-immunostaining (Fig. 1C, D) . 248
Proliferating cells were present 24 hours following MCT, peaking by 15 days 249 post MCT and remaining markedly elevated at 30 days. We specifically 250 addressed endothelial proliferation with double-staining techniques and 251 confocal microscopy. (Fig. 1E ). Using VE-cadherin staining to decorate EC 252 and proliferation marker Ki67 we found low EC proliferation on control 253 sections and 24 hours post MCT. Endothelial proliferation increased at 15 254 days and peaked at 30 days post-MCT.
12
VE-cadherin is downregulated in monocrotaline-induced pulmonary 256 hypertension 257
Protein levels of VE-cadherin by immunoblotting decreased 258 significantly 24 hours and 15 days post MCT challenge compared to saline-259 treated animals ( Fig. 2A, B ) but rebounded to control levels by Day 30 (Fig.  260   2A, B) . In multiple repetitions of the experiment by two different laboratories, 261
we found the magnitude of VE-cadherin reduction to be approximately 40-262 50% by this semiquantitative method. There was a corresponding down-263 regulation of VE-cadherin mRNA by semiquantitative PCR, mostly evident 24 264 hours and 15 days after MCT injection (Fig. 2D, E) . Caveolin-1, another 265 protein with abundant endothelial expression, followed similar kinetics up to 266 15 days, but failed to recover to baseline levels on day 30 (Fig. 2C) . The temporal relationship between VE-cadherin depletion and 271 mesenchymal cell proliferation, as assessed by mesenchymal markers α-272 smooth muscle actin (α-SMA) and vimentin, was studied. Using 273 immunohistochemistry, α-SMA was found overexpressed in the endothelial 274 layer and vessel wall of medium and small pulmonary arteries and veins of 275 rats treated with MCT (Fig. 3A) . Cells stained positively for α-SMA were also 276 found within the alveolar septae (Fig. 3B) . Immunostaining for vimentin 277 revealed increased expression of the protein 24 hours, 15 days and 30 days 278 post MCT challenge (Fig. 3C ). Vimentin staining was seen both in an 279 13 endothelial, perivascular as well as alveolar septal distribution; moreover, 280 vimentin expression was documented semi-quantitatively on homogenized 281
tissues from rats of all groups by immunoblotting (Fig. 3D, E) . To seek for 282 cells expressing endothelial and mesenchymal markers, we performed double 283 immunofluorescence staining of lung tissue sections with endothelial marker 284 PECAM-1 and α-SMA (Fig 4) . Using confocal microscopy, we observed that 285 To explore causes of low VE-cadherin levels by MCT we assessed for 298 apoptotic cell death by immunohistochemistry for cleaved caspase-3 in the 299 entire lung (Fig. 5A, B) . As expected, only few apoptotic cells were seen in 300 control lungs. Monocrotaline induced a relatively small increase in caspase-3-301 positive cells, which climbed steadily throughout the 30-day observation 302 period. We then specifically looked at endothelial apoptosis by double 303 14 immunofluoresence staining and confocal microscopy for caspase-3 and 304 endothelial-cell marker von-Willebrand Factor (vWF) (Fig. 5C ). Using this 305 method we identified apoptotic EC within several small vessels after MCT 306 exposure, primarily in the later time points (15 and 30 days post-MCT). 307 308
Transcriptional repression of Vascular Endothelial cadherin is 309
temporally related to monocrotaline-induced lung inflammation and 310
nitrosative stress 311
We searched for transcriptional regulators of VE-cadherin to explain 312 the observed drop in its expression and found that treatment with MCT, 313 especially at the time points of 24 hours and 15 days, caused significant 314 induction of VE-cadherin repressors Snail and Slug (Fig. 6A-C) . Snail 315 expression was evident by PCR within 24 hours into the model and had 316 subsided by day 30; in contrast, Slug expression was detectable on day 15 317 and remained elevated by day 30 (Fig. 6A-C) . The putative involvement of 318 signaling pathways of oxidative/nitrosative stress and inflammation, which are 319 known to induce Snail and Slug expression (30), was subsequently studied. 320
Excess nitrosative stress in the setting of redox reactions triggered by MCT 321 was seen by immunohistochemical staining of lung tissues for nitrotyrosine 322 (Fig. 6D) . Staining was strongest at 24 hours and waned by day 30. 323
Concomitantly, activated (phosphorylated) eNOS as a source of free radicals 324 was detected by immunoblotting in lung tissue (Fig. 6E, F) . Protein kinase 325 B/Akt, an enzyme intimately involved in cell cycle control and signal 326 transducer of Epithelial-Mesenchymal Transition pathways (17) , also 327 phosphorylates eNOS and was found strongly activated in lung tissue 328 homogenates by MCT predominantly at the day 15 time-point (Fig. 6E, F) . 329
Finally, we examined the state of NF-κB, which can activate Snail transcription 330 by direct binding on its promoter, (5) by immunoblotting for its inhibitor, IκB-α. 331
Degradation of IκB-α, corresponding to NF-κB activation, was strongest at 24 332 hours and 15 days post MCT (Fig. 6E, F) . 333 334
Endothelin-1 drives endothelial-to-mesenchymal transition in cultured 335
lung endothelial cells through eNOS activation 336
To determine the role of eNOS in VE-cadherin transcriptional 337 regulation, we challenged cultured rat lung EC (please see "Methods-Cell 338 culture and treatment") with endothelin-1 (ET-1), a known activator of eNOS 339 (19) as well as potent vasoconstrictor (34) and inducer of proliferation in PAH 340 (31). After confirming increased levels of ET-1 by immunohistochemistry in 341 our model (Fig. 7A) , we directly examined the potential of ET-1 to promote 342 endothelial transdifferentiation in vitro starting with its effect on VE-cadherin 343 expression. Exposure of EC to 10 nM ET-1 for five hours promoted VE-344 cadherin protein (Fig. 7B, C ) and mRNA downregulation (Fig. 8A, B) . This 345 was associated with a concomitant induction of vimentin and α-SMA 346 expression, evident by immunoblotting (Fig. 7B, D, E) , while Snail mRNA 347 levels were significantly increased (Fig. 8C, D) . In addition, activation of 348 eNOS, Akt and Nf-κB were also detected (Fig. 8E) . Pre-treatment with eNOS 349 inhibitor L-NAME prevented activation of Akt and Nf-κB (Fig. 8E) , thus 350 abolishing Snail transcription (Fig. 8C, D) , vimentin/α-SMA induction (Fig. 7B,  351 16 D, E) and preserving levels of VE-cadherin mRNA and protein (Fig. 7B, C stress. Injection of rats with MCT produced a significant reduction of VE-361 cadherin at 24 hours and 15 days, with recovery after four weeks ( Fig. 2A, B) . 362
In parallel, several morphologic changes involving the lung's vascular 363 structure were identified, including EC hyperproliferation and apoptosis (Fig.  364 1B-E, Fig. 5 ), endothelial monolayer discontinuity (Fig. 2E and Fig. 4) , smooth 365 muscle hyperplasia, and induction of mesenchymal markers α-SMA and 366 vimentin (Fig. 3, 4) . Using double immunofluorescence we identified cells co-367 expressing α-SMA and endothelial marker PECAM-1 (Fig. 4) . The size of this 368 subpopulation is difficult to quantify by this technique and it is almost certainly 369 subject to substantial variability. However, the presence of these cells does 370 imply an endothelial phenotypic shift, whereby cells of endothelial origin 371 acquire mesenchymal features, including contractility and collagen secretion. 372
During this transition, cells seem to briefly co-express a hybrid pattern of 373 markers, as captured in our experiment. Their potential pathogenetic role 374 could lie in mediating vascular remodeling and neovascularization. 375
Importantly, since these cells can be found in normal lungs at much lower 376 17 numbers and α-SMA content, it is conceivable that this remodeling process 377 takes place constitutively and is accelerated in response to endothelial injury. 378
Our finding is in line with studies by Qiao et al. (25) in human and 379 monocrotaline-pyrrole-challenged mouse lungs, as well as by Ranchoux et al. 380 in human lungs from PAH patients (27). In contrast, in a study using the 381 Sugen/hypoxia model, no appreciable co-expression of endothelial and 382 mesenchymal markers was found (22). Of note, VE-cadherin downregulation 383 occurs early and seems associated with the inflammatory and nitrosative 384 stress response. Expression of VE-cadherin ultimately rebounds at a faster 385 pace than Caveolin-1 and this likely indicates vascular remodeling by 386 transformed EC responding to angiogenic and proliferative stimuli rather than 387 true recovery ( Fig. 2A, B) . 388
We assessed for EC death as a cause of VE-cadherin drop in 389 response to MCT, since its active metabolite, MCT-pyrrole, is known to 390 mediate EC death directly or by inducing caspase-3-mediated apoptosis (28). 391
To this end, we quantified the extent of cell apoptosis by measuring activated 392 caspase-3-positive cells in immunohistochemically stained rat lungs (Fig 5A,  393 B). Monocrotaline administration was associated with accelerated apoptosis 394 rate, starting at 24 hours and peaking at day 30. Using double-395 immunofluoresence, we found that a fraction of apoptosis affects the 396 endothelium, primarily at the later time points (Fig.5C ). This however, is 397 unlikely to explain the reduction in VE-cadherin in its entirety. In contrast to 398 apoptosis, VE-cadherin expression declined early on and was restored by day 399 30. Furthermore, the number of apoptotic cells in the lung at baseline and 400 after MCT is too low to account for a VE-cadherin reduction of approximately 401 18 40-50% ( Fig. 2A, B) . The relatively bland histology of the lungs after 24 hours 402 of MCT also argues against extensive necrosis. We therefore suggest that the 403 diminished VE-cadherin expression is more likely a manifestation of sub-lethal 404 cellular injury. This is supported by previous reports of decreased Endothelial Cell Adhesion Molecule-1 but not von Willebrand factor in the 406 MCT rat model (20) . Interestingly, the time course of apoptosis correlates 407 better with that of cellular proliferation, as documented by cell division 408 markers PCNA (Fig. 1C, D) and Ki67 (Fig. 1E) , indicating active EC turnover. 409
We investigated transcriptional repression as a cause of reduced VE-410 cadherin and found a decrease in mRNA level to parallel the protein data. We 411 then explored the role of Snail and Slug, known transcriptional inhibitors of 412 VE-cadherin (4, 21), in controlling VE-cadherin downregulation. In rat lung 413 tissue there was an early augmentation of Snail expression documented by 414 PCR, which peaked on day 15 and subsided by day 30 (Fig. 6A, B) . Of note, 415
Slug appeared later in the course but stayed active on day 30 (Fig. 6A, C) . 416
The temporal shift in the expression of these factors indicates that their role is 417 not interchangeable. Consistent with this notion is the finding that Snail is 418 induced preferentially by TGF-β, whereas Slug expression is the result of 419 Notch activity (21). These pathways presumably operate in tandem, with TGF-420 b initiating a process of vascular transformation further to be sustained by 421 
